Pituitary thyrotroph hyperplasia secondary to primary hypothyroidism is a rare cause of pituitary enlargement. We report a case of pituitary hyperplasia in a young woman thought to have a pituitary macroadenoma with suprasellar extension. A 21-year-old woman was admitted to our hospital, complaining of menstrual irregularity and galactorrhea. Serum thyrotropin and prolactin were high, and serum-free thyroxine was low. Magnetic resonance imaging revealed symmetrical pituitary enlargement associated with contrast enhancement simulating macroadenoma. After adequate hormone replacement therapy with levothyroxine, both symptoms and pituitary hyperplasia regressed within 4 months. It is concluded that pituitary tumor associated with elevated thyroid stimulating hormone and low levels of free T4 should always be treated with replacement thyroxine before other diagnostic tests are ordered.Key Words: pituitary hyperplasia, primary hypothyroidism, MR imaging (The Endocrinologist 2010;20: 168 -170) P ituitary hyperplasia and sella turcica enlargement is often associated with long-standing primary hypothyroidism. 1-5 Thyrotroph cell hyperplasia is believed to be caused by the lost of the negative feedback exerted by thyroid hormones. 6 The large hyperplastic pituitary can mimic a pituitary tumor 3,7-10 with the presence of hyperprolactinemia due to stalk compression or the effects of increased hypothalamic thyrotropin-releasing hormone (TRH) on prolactin secretion. [11][12][13] Regression of the pituitary hyperplasia in patients with primary hypothyroidism follows thyroid hormone replacement therapy. 3,7-9, 14 We now report a case of a woman with primary hypothyroidism and magnetic resonance imaging (MRI) findings of a pituitary macroadenoma, which regressed after 4 months of thyroid hormone therapy.
CASE REPORTA 21-year-old woman had a 2-year history of irregular menstrual cycles, galactorrhea, and headaches. The patient received no medications and did not smoke or use alcohol. There was no family history of thyroid disease, pituitary tumors, or infertility. Review of systems disclosed "lifelong" cold intolerance, fatigue, and constipation. Her blood pressure was 110/70 mm Hg, and heart rate was 74 per minute. Visual fields were grossly intact, and there was no proptosis. The thyroid gland was nonpalpable. Expressible galactorrhea was present. The skin was dry and cool. Routine laboratory tests and chest x-ray were normal. Antithyroglobulin antibody titer, 194 IU/mL (N Ͻ115); antithyroid peroxidase antibody titer, 99.9 IU/mL (N Ͻ34); serum thyroid-stimulating hormone (TSH) levels, 100 mIU/L (normal range, 0.27-4.2); serum total triiodothyronine (TT 3 ) was 0.81 ng/mL (normal range, 0.8 -2.0); serum total thyroxine (TT 4 ), 2.28 g/dL (normal range, 5.1-14.1); serum-free triiodothyronine (FT 3 ) was 2.29 pg/mL (normal range, 1.8 -4.6); and free thyroxine (FT 4 ) was 0.24 ng/dL (normal range, 0.9 -1.7). Prolactin (PRL) was 97 ng/mL (N: 3.4 -24.1); follicle-stimulating hormone, 2.67 mIU/mL (N: 1.5-12.4); luteinizing hormone,...